Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
OTCMKTS:DGNOF

DIAGNOS (DGNOF) Stock Price, News & Analysis

→ Biden Nomination CANCELED? (From The Freeport Society) (Ad)
Free DGNOF Stock Alerts
$0.22
-0.01 (-2.35%)
(As of 05/17/2024 08:55 PM ET)
Compare
Today's Range
$0.22
▼
$0.23
50-Day Range
$0.18
▼
$0.25
52-Week Range
$0.18
▼
$0.43
Volume
15,000 shs
Average Volume
28,787 shs
Market Capitalization
$17.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsHeadlinesShort Interest
DGNOF stock logo

About DIAGNOS Stock (OTCMKTS:DGNOF)

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

DGNOF Stock Price History

DGNOF Stock News Headlines

May 14, 2024 | americanbankingnews.com
DIAGNOS (OTCMKTS:DGNOF) Shares Down 2.8%
May 9, 2024 | globenewswire.com
DIAGNOS Announces Closing of First Tranche of Private Placement
May 6, 2024 | globenewswire.com
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
April 16, 2024 | globenewswire.com
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
April 9, 2024 | globenewswire.com
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
April 3, 2024 | globenewswire.com
DIAGNOS Announces Grant of Stock Options
April 2, 2024 | globenewswire.com
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
March 22, 2024 | globenewswire.com
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
March 4, 2024 | globenewswire.com
DIAGNOS Announces Grant of Stock Options
February 29, 2024 | globenewswire.com
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors
February 27, 2024 | globenewswire.com
DIAGNOS Announces Closing of First Tranche of Private Placement
February 23, 2024 | globenewswire.com
Diagnos Announces Variation in One Insider Ownership of Common Shares
February 21, 2024 | globenewswire.com
DIAGNOS recognized as a Top TSX Venture Exchange Company
December 8, 2023 | nytimes.com
Best of 2023
See More Headlines

Company Calendar

Last Earnings
2/28/2024
Today
5/19/2024
Fiscal Year End
3/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Business Services
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:DGNOF
CUSIP
N/A
CIK
N/A
Web
www.diagnos.ca
Phone
(450) 678-8882
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,880,000.00
Net Margins
-1,553.79%
Pretax Margin
-1,032.49%
Return on Equity
N/A
Return on Assets
-297.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.79
Quick Ratio
0.79

Sales & Book Value

Annual Sales
$370,000.00
Price / Sales
46.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-11.20

Miscellaneous

Outstanding Shares
76,650,000
Free Float
N/A
Market Cap
$17.17 million
Optionable
Not Optionable
Beta
0.19

Key Executives

  • Mr. Andre Larente
    CEO, President & Executive Chairman
  • Mr. Marc-André Massue
    VP of Finance, CFO & Secretary
  • Mr. Yves-Stéphane Couture
    Chief Operating Officer
  • Mr. Martin Beland
    Director of Marketing

Key Competitors

View All Competitors

DGNOF Stock Analysis - Frequently Asked Questions

How have DGNOF shares performed in 2024?

DIAGNOS's stock was trading at $0.3050 at the beginning of 2024. Since then, DGNOF shares have decreased by 26.6% and is now trading at $0.2240.
View the best growth stocks for 2024 here.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (OTCMKTS:DGNOF) posted its earnings results on Wednesday, February, 28th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.04 million for the quarter.

How do I buy shares of DIAGNOS?

Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DGNOF) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Urgent Nvidia Warning
Altimetry
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Global crypto currency reset (41 major banks signed up)
Stansberry Research
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders